Detail Hasil Pencarian

Judul :
Demensia ( tinjauan aspek definisi, etiologi, demografi, epidemiologi, dan faktor risiko )
Pengarang : Bambang Hartono
Jurnal : Berkala Neuro Sains 2000, II(1)
Tahun : 2000
Summary / Kata Kunci : Prevalence studies on dementia have reported a positive association with age. Because of the ageing of the world's population, in the future there will be relatively more people in the age groups at most risk for dementia. Alzheimer's disease and vascular dementia are the most common form of dementia. Its prevalence and incidence rate tend to give different results, influencing by age, gender, race/ethnic, geographic, rural/urban areas, and levels of education factors. The most significant risk factors are age, gender, genetic, environment, education, cardio-cerebrovascular, hormonal, and lifestyle. It is suggested to develop studies for setting up a screening and diagnosing tool of dementia in Indonesia, which adapted to the local social-life and culture, then the multi-center studies might be done afterwards.

Keywords; dementia - prevalence- incidence- risk factors-alzheimer's disease
File : Login Required
     
Sitasi  
    (tidak ada sitasi)
     
Referensi    
1.   0lafsdottir M, Skoog I, Marcusson J., Detection of dementia in primary care: the Linkoping study., 2000
2.   2000Reischies FM, Diefenbacher A., Dementia screening in psychiatric consultation for elderly patients in a general hospital., 2000
3.   Aguero-Torres H, Winblad B., Alzheimer's disease and vascular dementia. Some points of confluence, 2000
4.   Alzheimer's Disease International, Alzheimer's disease and genetics. Alzheimer's disease as a genetic disorders, 1999
5.   Alzheimer's Disease International (ADI)., Organization of a prevalence study. A community study must be carefully planned if it is to have any validity., 1999
6.   Alzheimer's Disease International (ADI).., The prevalence of dementia., 1999
7.   American Psychiatric Association., Diagnostic and Statistical Manual of Mental Disorders, 4rd ed, (DSM-IV)., 1994
8.   Andersen K, Lolk A, Nielsen H., Prevalence and incidence of dementia in Denmark., 2000
9.   Andrews NJ, Farrington CP, Cousens SN., Incidence of variant Creutzfeldt-Jakob disease in the UK., 2000
10.   Anthony JC, Breitner JC, Zandi PP., Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Chache County study, 2000
11.   Baker FM, Jordan B, Barclay L., Risk factors for clinically diagnosed Alzheimer's disease., 1993
12.   Ballard C, Neill D, O'Brien J., Anxiety, depression and psychosis in vascular dementia: prevalence and associations., 2000
13.   Barba R, Martinez-Espinosa S, Rodriguez-Garcia E., Post stroke dementia: clinical features and risk factors., 2000
14.   Berg L, Morris JC. Diagnosis. In Terry RD, Katzman R, Bick KL, (eds):, Alzheimer Disease., 1994
15.   Bickel H., Dementia syndrome and Alzheimer's disease: an assessment of morbidity and annual incidence in Germany., 2000
16.   Breteler MM., Vascular risk factors for Alzheimer's disease: an epidemiologic perspective, 2000
17.   Carnicioli R, Willert P, Lear J., Dementia in rural primary care practices in Lake County, Oregon., 2000
18.   CSHA (The Canadian Study of Health and Aging Working Group).., The incidence of dementia in Canada., 2000
19.   Debanne SM, Rowland DY, Riedel TM., Association of Alzheimer's disease and smoking: the case for sibling controls., 2000
20.   Dharmaperwira-Prins RII, Bayles KA, Tomoeda CK.., IBCD (Indonesian Battery for Communication Disorder of Dementia) ed 2, 1999
21.   Di Carlo A, Baldereschi M, Arnaducci.., Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging. J, 2000
22.   Elias MF, Beiser A, Wolf PA., The preclinical phase of Alzheimer's disease: A 22-year prospective study of the Framingham Cohort., 2000
23.   Emmerling MR, Morganti-Kossmann MC, Kosmann T., Traumatic brain injury elevates the Alzheimer's amyloid peptide A beta 42 in human CSF. A possible role for nerve cell injury., 2000
24.   Fratiglioni L, Launer LJ, Andersen K., Incidence of dementia and major subtypes in Europe: A collaborative study of population-base cohorts., 0000
25.   Ganguli M, Chandra V, Kamboh MI., Apolipoprotei n E polymorphism and Alzheimer disease: The indo-US cross National Dementi Study, 2000
26.   Gao S, Hendrie HC, Kathleen S., The relation between age, sex, and the incidence of dementia and Alzheimer disease., 1998
27.   Geerlings, MI, Schmand B, Braam AW., Depressive symptoms and risk of Alzheimer's disease in more highly educated older people., 2000
28.   Giladi N, Treves TA, Paleacu D., Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease., 2000
29.   Hall KS., Gao S, Emsley CL., Community screening interview for dementia (CSI 'D'); Performance in five disparate study sites, 2000
30.   Hargrave R, Stoekl in M, Haan M., Clinical aspects of dementia in African-American, Hispanic, and white patients., 2000
31.   Hebert R, Lindsay J, Verreault R, Incidence and risk factors in the Canadian, 2000
32.   Hendrie HC, Hall KS, Pillay N., Alzheimer's disease is rare in Cree. Int Psychogeriatry, 1993
33.   Hendrie HC, Osuntokun BO, Hall KS., Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans., 1995
34.   Hirono N, Yasuda M, Tanimukai S., Effect of apolipoprotein E epsilon 4 allele on white matter hyperintensities in dementia., 2000
35.   Hofman A, Rocca WA, Brayne C., The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings., 1991
36.   Holland AJ, Hon J, Huppert FA., Incidence and course of dementia in people with Down's syndrome: finding from a population-based study., 2000
37.   Hoyert DL, Rosenberg HM., Alzheimer's disease as a cause of death in the United States., 2000
38.   Ineichen B. A review., The epidemiology of dementia in Africa:, 2000
39.   Inzitari D, Erkinjuntti T, Wallin A., Subcortical vascular dementia as a aspecific target for clinical trials., 2000
40.   Janicki MP, Dalton AJ., Prevalence of dementia and impact on intellectual disability services., 2000
41.   Jorm A.F., Cross-National comparisons of the occurrence of Alzheimer's and vascular dementias., 1991
42.   Jorm AF, Korten AE, Henderson AS., The prevalence of dementia: a quantitative integration of the literature., 2000
43.   Kamino K, Nagasaka K, Imagawa M., Deficiency in mitochondria' aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population. Biochem Biophys Res Commun, 2000
44.   Kawas C, Gray S, Brookmeyer R., Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging., 2000
45.   Kertesz A, Nadkarni N, Davidson W., The frontal behavioral inventory in the differential diagnosis of frontotemporal dementia, 2000
46.   Letenneur L, Launer LJ, Andersen K., Education and the risk for Alzheimer's disease: sex makes a difference. EURODEM pooled analyses., 2000
47.   Lobo A, Launer LJ, Fratiglioni L., Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts., 2000
48.   Loewenstein DA., Barker WW, Harwood DG., Utility of a modified Mini-Mental State Examination with extended delayed recall in screening for mild cognitive impairment and dementia among community dwelling elders., 2000
49.   Makin N, Ikeda M, Hokoishi K., The validity of the MMSE and SMQ as screening tests for dementia in the elderly general population-a study of one rural community in Japan., 2000
50.   Martin BC, Ricci JF, Kotzan JA., The net cost of Alzheimer disease and related dementia: a population-based study of Georgia Medicaid recipients. Alzheimer Dis Assoc Disord, 2000
51.   Meyer JS, Rauch GM, Rauch RA., Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia, 2000
52.   Meyers JS, Rauch G, Rauch RA., Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia, 2000
53.   Mitchell SL, Rockwood K., The association between parkinsonism, Alzheimer's disease, and mortality: a comprehensive approach., 2000
54.   Nishiyama M, Kato Y, Hashimoto M., Apolipoprotein E ethylenetetrahydrofolate reductase (MTHFR) mutation and the risk of senile dementia-an epidemiological study using the polymerase chain reaction (PCR) method., 2000
55.   Orrell M, Butler R, Bebbington P., Social factors and the outcome of dementia. Int J Geriatr Psychiatry, 2000
56.   Pasquier F, Henon H, Leys D., Relevance of white matter changes to pre- and poststroke dementia, 2000
57.   Prince MJ, Cullen MC, Mann AH., Risk factors for Alzheimer's disease and dementia: A case-control study based on the MRC Elderly Hypertension Trial., 1994
58.   Razdan S, Kaul RL, Mona A., Prevalence and pattern of major neurological disorders in rural Kashmir (India) in 1986, 1994
59.   Richards SS, Emsley CL, Roberts J., The association between vascular risk factor-mediating medications and cognition and dementia diagnosis in a community-based sample of African-Americans, 2000
60.   Riley KP, Snowdon DA, Saunders AMCognitive, function and apolipoprotein E in very old adults: findings from the Nun study, 2000
61.   Rockwood K, Macknight C, Wentzel C., The diagnosis of "mixed" dementia in the Consortium for the Investigation of Vascular Impairment of Cognition (CIVIC)., 2000
62.   Rondeau V, Commenges D, Jacqmin-Gadda H., Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study., 2000
63.   Sevush S, Peruyera G, Crawford F, . Apolipoprotein-E epsilon 4 allele frequency and conferred risk for Cuban Americans with Alzheimer's disease, 2000
64.   Shaji S, Promodu K, Abraham T., An epidemiological study of dementia in a rural community in Kerala, India., 1996
65.   Shi J, Perry G, Smith MA., Vascularabnormalities: the insidious pathogenesis of Alzheimer's disease, 2000
66.   Stoppe G., Dementia: risk and protective factors with special consideration of gender and hormone replacement therapy., 2000
67.   Thomas NJ, Morris CM, Scaravilli F., Hereditary vascular dementia linked to notch 3 mutations. CADASIL in British families, 2000
68.   Tyas SL, Koval JJ, Pederson LL, Does an interaction between smoking and drinking influence the risk of Alzheimer's disease. Results from three Canadian data sets, 2000
69.   United Nation / Dept for Economic and Social Information and Policy Analysis Population Division., The sex and age distribution of the world population: the 1994 revision., 1994
70.   Vilalta-Franch J, Lopez-Pousa S, LlinasRegla J., The prevalence of dementias in a rural area. A study in Girona., 2000
71.   Visser PJ, Verhey FR, Ponds RW., Distinction between preclinical Alzheimer's disease and depression, 2000
72.   Xuereb JH, Brayne C, Dufouil C., Neuropathological findings in the very old. Results from the first 101 brains of a population-based longitudinal study of dementing disorders, 2000
73.   Zhang M, Katzman R, Salmon D. Ann Neurol, The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education., 1990
74.   Zhu L, Fratiglioni L, Guo Z., Incidence of stroke in relation to cognitive function and dementia in the Kungsholmen Project., 2000
     
     
Inherent UGM
Gedung Pusat UGM
Lt 3 Sayap Utara
Bulaksumur
Telp. (0274) 564416